Pricing Log in Create free account
Friday 6 November 2026 Export NVO’s income statement to Excel — free account

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.

Revenue
+4.47%
EPS
−18.7%
Free cash flow
+71.6%
Total debt
+44.4%

Quarter to June 2026, against a year earlier

40.33 1.85 −4.39%
Market cap
$134.8B
P/E
9.9×
Fwd P/E
—
Dividend yield
4.45%
F-score
5/9
Altman Z
4.32
Beneish M
−2.51
Dividend safety
46/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Novo Nordisk A/S (NVO) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Novo Nordisk A/S (NVO) trades at a P/S ratio of 3.5×. Over the past ten years it has ranged from 3.2× (April 2026) to 18.4× (June 2024); the current reading is higher than 2% of that period. That is in line with the Drug Manufacturers General industry median of 3.5× and in line with the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.8× (46.90%)
FY2024 9.1× (32.97%)
FY2023 13.6× 9.62%
FY2022 12.4× 7.82%
FY2021 11.5× 36.98%
FY2020 8.4× 11.58%
FY2019 7.5× 15.22%
FY2018 6.5× (17.41%)
FY2017 7.9× 44.30%
FY2016 5.5× (41.17%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 4.1× 28.96%
Mar 2026 3.2× (33.67%)
Dec 2025 4.8× (8.53%)
Sep 2025 5.3× (21.68%)
42 more quarters

Against its own ten years

Low 3.2× High 18.4×
Ten-year median 8.2×
Current reading's percentile 2

P/S ratio against peers

Company P/S ratio
SNY Sanofi compare 1.9×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.6×
PFE Pfizer Inc. compare 2.7×
NVO Novo Nordisk A/S 3.5×
AZN AstraZeneca PLC compare 4.7×
NVS Novartis AG compare 5.4×
AMGN Amgen Inc. compare 6.4×
GILD Gilead Sciences, Inc. compare 6.7×
Drug Manufacturers General industry median 3.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on NVO